Once Again, Smoke From Canadian Wildfires Envelops Many American Cities
Between 80 million and 120 million people are affected by this poor air quality
ADA: Reductions in Body Weight With Retatrutide for Obesity
Substantial reductions seen in body weight with retatrutide treatment for 48 weeks in phase 2 trial
Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer
Black race linked to increased risk of uncontrolled risk factors; higher rates for patients with larynx cancer
CVD Risk Factors Predict Risk of Common Musculoskeletal Disorders
Authors found 17-fold increased risk for four or more MSDs and say findings point to need to prioritize cardiovascular health improvement
Benefits of Indefinite Anticoagulant Unclear After First VTE
Indefinite anticoagulation prevented recurrent VTE events, but induced major bleeding events
2006 to 2019 Saw Significant Drop in Nicotine Dependence Prevalence
Adjusted prevalence of nicotine dependence was lower for those aged 18 to 25, 26 to 34, 35 to 49 versus those aged 50 and older
Recollection of Grief Following Death of Loved One Tied to BP Increases
Severity of grief tied to greater increases in blood pressure
Posthospitalization Meal Delivery Boosts Outcomes for Older Adults
Findings for 30-day rehospitalization and mortality in patients with and without heart failure
ADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
Substantial and clinically meaningful reductions in body weight seen for adults with obesity and type 2 diabetes
ADA: Once-Daily Semaglutide Superior for Reduction in Body Weight
Superior and clinically meaningful reduction in body weight in adults with overweight, obesity without type 2 diabetes
